CoChat

ACTsmart: Guided Smartphone-Delivered Acceptance and Commitment Therapy for Chronic Pain—A Pilot Trial.

Open access

The DOI matches its Crossref record; 81 of the 87 references it cites were found in a registry or an index; 28 of the 66 sources its claims cite were checked for support.

Abstract

Background Acceptance and commitment therapy (ACT) is a behavioral health intervention with strong empirical support for chronic pain but, to date, widespread dissemination is limited. Digital solutions improve access to care and can be integrated into patients' everyday lives. Objective ACTsmart, a guided smartphone-delivered ACT intervention, was developed to improve the accessibility of an evidence-based behavioral treatment for chronic pain. In the present study, we evaluated the preliminary efficacy of ACTsmart in adults with chronic pain. Methods The study was an open-label pilot trial. The treatment lasted for 8 weeks, and participants completed all outcome measures at pretreatment and posttreatment and at 3-, 6-, and 12-month follow-ups, with weekly assessments of selected measures during treatment. The primary outcome was pain interference. The secondary outcomes were psychological flexibility, values, insomnia, anxiety, depressive symptoms, health-related quality of life, and pain intensity. All outcomes were analyzed using linear mixed-effects models. Results The sample consisted of 34 adults (88% women) with long-standing chronic pain (M =20.4 years, SD=11.7). Compliance to treatment was high, and at the end of treatment, we observed a significant improvement in the primary outcome of pain interference (d = –1.01). All secondary outcomes significantly improved from pretreatment to posttreatment with small to large effect sizes. Improvements were maintained throughout 12 months of follow-up. Conclusion The results of this pilot study provide preliminary support for ACTsmart as an accessible and effective behavioral health treatment for adults with chronic pain and warrant a randomized controlled trial to further evaluate the efficacy of the intervention.

Overview

CoChat Summary

## TL;DR

This open-label pilot trial found that 8 weeks of guided smartphone-delivered ACT (ACTsmart) was associated with significant posttreatment improvements in pain interference and all secondary outcomes in 34 adults with chronic pain, with gains maintained through 12 months. The authors present the results as preliminary support for a randomized controlled trial, while noting important design limitations.

## Key findings

  • The sample included 34 adults; 88% were women, mean age was 44.4 years, and mean pain duration was 20.4 years (SD = 11.67).
  • At end of treatment, the primary outcome of pain interference improved significantly with a large effect size (d = –1.01).
  • All secondary outcomes improved significantly from pretreatment to posttreatment, with effect sizes ranging from d = 0.16 for health-related QoL to d = –1.34 for avoidance; improvements were maintained through 12 months.
  • Treatment completion was high: among the 31 participants who remained after pre-treatment attrition, 28 (90%) met completion criteria; therapists spent an average of 16 minutes per patient per week.
  • No serious adverse events were reported, but 11 participants (35%) showed clinically significant deterioration (>30%) at posttreatment, and 6 (19%) still had deterioration at the end of follow-up.

## Methods

  • Design: Open-label pilot trial with one intake at a tertiary pain clinic; treatment lasted 8 weeks with assessments at pretreatment, posttreatment, and 3-, 6-, and 12-month follow-ups, plus weekly assessments during treatment.
  • Sample/data: 34 adults with chronic pain recruited by self-referral via social media; eligibility required pain for at least 6 months, age 18–70, Swedish language ability, and internet-connected smartphone/tablet, among other criteria.
  • Analysis: Outcomes were analyzed using intent-to-treat linear mixed-effects models with full-information maximum-likelihood estimation; effect sizes were calculated for pretreatment-to-posttreatment and posttreatment-to-follow-up change.

## Limitations

  • The paper explicitly states limitations of no control condition, small sample size, predominance of female participants, and missing data at 12 months.
  • The authors also note that the self-referred sample may reduce external validity because such patients may be more healthy, better educated, and more motivated than clinical patients.
  • Evident from the text: this is an open-label pilot with therapists trained in ACT and chronic pain, so the results may not generalize to less specialized clinical settings.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/pm/pnaa360

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Screenshots of the patient interface in ACTsmart (translated from Swedish to English).
Figure 1. Screenshots of the patient interface in ACTsmart (translated from Swedish to English).CC BY-NC-ND · PubMed Central
Figure 2. Participant flow throughout treatment.
Figure 2. Participant flow throughout treatment.CC BY-NC-ND · PubMed Central
Figure 3. Estimated means for pain interference for pretreatment, during treatment, and posttreatment (pretreatment to posttreatment d = –1.01). For illustrative purposes, time was used as a discrete variable to model weekly estimates to the mean.
Figure 3. Estimated means for pain interference for pretreatment, during treatment, and posttreatment (pretreatment to posttreatment d = –1.01). For illustrative purposes, time was used as a discrete variable to model weekly estimates to the mean.CC BY-NC-ND · PubMed Central
Figure 4. Estimated means for avoidance for pretreatment, during treatment, and posttreatment (pretreatment to posttreatment d = –1.34). For illustrative purposes, time was used as a discrete variable to model weekly estimates to the mean.
Figure 4. Estimated means for avoidance for pretreatment, during treatment, and posttreatment (pretreatment to posttreatment d = –1.34). For illustrative purposes, time was used as a discrete variable to model weekly estimates to the mean.CC BY-NC-ND · PubMed Central
Figure 5. Estimated means for value progress for pretreatment, during treatment, and posttreatment (pretreatment to posttreatment d = 0.78). For illustrative purposes, time was used as a discrete variable to model weekly estimates to the mean.
Figure 5. Estimated means for value progress for pretreatment, during treatment, and posttreatment (pretreatment to posttreatment d = 0.78). For illustrative purposes, time was used as a discrete variable to model weekly estimates to the mean.CC BY-NC-ND · PubMed Central
Figure 6. Estimated means for value obstruction for pretreatment, during treatment, and posttreatment (pretreatment to posttreatment d = –1.02). For illustrative purposes, time was used as a discrete variable to model weekly estimates to the mean.
Figure 6. Estimated means for value obstruction for pretreatment, during treatment, and posttreatment (pretreatment to posttreatment d = –1.02). For illustrative purposes, time was used as a discrete variable to model weekly estimates to the mean.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

16 Valid · 0 Not valid · 12 Not checked · 28 Own results and interpretations

10 more claims

Create a free account to see all 56 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 35
  • Probably not a substantial claim. 17
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 20

Metadata

Authors
Gentili, C., Zetterqvist, V., Rickardsson, J., Holmström, L., Simons, L. E., & Wicksell, R. K.
Affiliations
  • Karolinska University Hospital (SE)
  • Uppsala University (SE)
  • Stanford Medicine (US)
  • Karolinska Institutet (SE)
Corresponding author
Gentili, Charlotte
Venue
Pain Medicine
Published
2020-11-16
Volume
22
Issue
2
Pages
315-328
ISSN
  • 1526-2375 (ISSN-L)
  • 1526-4637
OpenAlex
W3105460477
Cited by
20
References
87
Citations by year
2026: 4 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 1
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • Pain Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
Funders
Karolinska Institutet
Topics
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
Keywords
acceptance and commitment therapy, chronic pain, smartphone-based intervention, digital mental health, pain interference, psychological flexibility, values, insomnia, anxiety, depressive symptoms, health-related quality of life, medication adherence
MeSH terms
Smartphone, Adult, Female, Humans, Male, Pilot Projects, Quality of Life, Treatment Outcome, Chronic Pain, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.